Drugs / parathyroid hormone 1-84
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02986607 | Mar 2016 → Jan 2018 | hyperparathyroidism, hypoparathyroidism | University of Bergen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | parathyroid hormone 1-84 | “PTH, Natpara (parathyroid hormone 1-84) 50 µg doses with a concentration of 800 µg/ml” NCT02986607 ↗ |
| Route | Subcutaneous | “Hypoparathyroidism patients will receive Natpara in continous subcutaneous infusion delivered by a pump for 4-7 days.” NCT02986607 ↗ |